Citation Impact
Citing Papers
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer
2008
A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease
2008
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Updated concepts and treatment of carcinoma in situ
1998
Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
2003
Optimal Management of the T1G3 Bladder Cancer
2005
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Oxidative stress, aging, and diseases
2018 Standout
T1G3 Bladder Tumours: The Case for Radical Cystectomy
2003
Recurrence at Three Months and High-grade Recurrence as Prognostic Factor of Progression in Multivariate Analysis of T1G2 Bladder Tumors
2009
Current perspectives in muscle invasive bladder cancer
2002
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
2011
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumours
2003
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder
2012
Inadequacy of Biopsy for Diagnosis of Upper Tract Urothelial Carcinoma: Implications for Conservative Management
2011
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Can patient selection for bladder preservation be based on response to chemotherapy?
2003
Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials
2007
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Urothelial Carcinoma of the Prostate
2007
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
2016 Standout
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
The clinical epidemiology of superficial bladder cancer
1993
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
2012
Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guérin
2011
Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma
2009
Seguimiento oncológico después de cistectomía radical basado en patrones de recidiva tumoral y sus factores de riesgo
2013
Bacillus Calmette‐Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression
2004
Urothelial carcinoma management in elderly or unfit patients
2016
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Upper Urinary Tract Transitional Cell Carcinoma: Recurrence Rate after Percutaneous Endoscopic Resection
2006
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer
2006
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder
2005
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
2012
Cystectomy in Patients with High Risk Superficial Bladder Tumors Who Fail Intravesical BCG Therapy:
2005
Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer
2012
Carcinoma of the upper urinary tract
2009
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
2008 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
2009 Standout
Invasive T1 bladder cancer: indications and rationale for radical cystectomy
2008
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
2015
EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
2011
Follow-up After Surgical Treatment of Bladder Cancer: A Critical Analysis of the Literature
2012
Is There a Role for FISH in the Management and Surveillance of Patients with Upper Tract Transitional-Cell Carcinoma?
2008
Protein Carbonylation in Skeletal Muscles: Impact on Function
2009
Natural History, Recurrence, and Progression in Superficial Bladder Cancer
2006
RESTAGING TRANSURETHRAL RESECTION OF HIGH RISK SUPERFICIAL BLADDER CANCER IMPROVES THE INITIAL RESPONSE TO BACILLUS CALMETTE-GUERIN THERAPY
2005
Behavior of Urothelial Carcinoma With Respect to Anatomical Location
2007
Role of Protein Carbonylation in Skeletal Muscle Mass Loss Associated with Chronic Conditions
2016
Bladder Cancer
2020 Standout
Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update
2007
Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up.
2007
Follow-up after radical cystectomy based on patterns of tumor recurrence and its risk factors
2013
EFFECTIVENESS OF A SINGLE IMMEDIATE MITOMYCIN C INSTILLATION IN PATIENTS WITH LOW RISK SUPERFICIAL BLADDER CANCER: SHORT AND LONG-TERM FOLLOWUP
1999
Upper Urinary Tract Recurrence Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis on 13,185 Patients
2012
Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant Therapy
2003 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update
2012
ASSESSMENT OF VESICOURETERAL REFLUX IN PATIENTS WITH SELF-RETAINING URETERAL STENTS: IMPLICATIONS FOR UPPER URINARY TRACT INSTILLATION
2005
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
CYSTECTOMY FOR BLADDER CANCER: A CONTEMPORARY SERIES
2001
Upper Tract Urothelial Recurrence Following Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: An Analysis of 1,069 Patients With 10-Year Followup
2007
Segmental Ureterectomy Can Safely be Performed in Patients With Transitional Cell Carcinoma of the Ureter
2010
Transurethral Resection of Muscle-Invasive Bladder Cancer: 10-Year Outcome
2001
Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma
2003
Extravesical Involvement in Patients with Bladder Carcinoma In Situ: Biological and Therapy Implications
1996
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma
2016
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of J. Casanova being referenced
Carcinoma in situ Associated with Superficial Bladder Tumor
1991
FEASIBILITY OF TRANSURETHRAL RESECTION FOR MUSCLE INFILTRATING CARCINOMA OF THE BLADDER: LONG-TERM FOLLOWUP OF A PROSPECTIVE STUDY
1998
Recurrence of Superficial Bladder Tumors in Prostatic Urethra
1991
Redox balance following magnetic stimulation training in the quadriceps of patients with severe COPD
2008
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer
2003
Bladder Preservation in Selected Patients with Muscle-Invasive Bladder Cancer by Complete Transurethral Resection of the Bladder Plus Systemic Chemotherapy: Long-Term Follow-up of a Phase 2 Nonrandomized Comparative Trial with Radical Cystectomy
2008
The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumour
2004
Conservative Elective Treatment of Upper Urinary Tract Tumors: A Multivariate Analysis of Prognostic Factors For Recurrence and Progression
2003
Conservative Elective Treatment of Upper Urinary Tract Tumors: A Multivariate Analysis of Prognostic Factors For Recurrence and Progression
2003
[Biological behavior of untreated bladder carcinoma in situ].
1991
Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
1995
Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer
2010
Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression.
2003
THE 3-MONTH CLINICAL RESPONSE TO INTRAVESICAL THERAPY AS A PREDICTIVE FACTOR FOR PROGRESSION IN PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER CANCER
2000
Disruption of basement membrane, extracellular matrix metalloproteinases and E-cadherin in renal-cell carcinoma.
2004